Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia

Chinese Journal of Contemporary Pediatrics

Volumn 9, Issue 6, 2007, Pages 526-528

  Yang, Hua Qiang ^a   Zhang, Rong Huan ^a   Zhang, Zheng Hua ^a   Wan, Chu Cheng ^a   Xia, Yun Jin ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Acute lymphoblastic leukemia; Child; Tissue factor; Vascular endothelial growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; THROMBOPLASTIN; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER REGRESSION; CANCER RISK; CHILD HEALTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKEMOGENESIS; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; THROMBOPLASTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38049086106     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, et al. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes [J]. Cancer, 2002, 95 (9): 1923-1930.
2. Chinese source.
3. Lykke J, Nielsen HJ. The role of tissue factor in colorectal cancer [J]. Eur J Surg Oncol, 2003, 29 (5):417-422.
4. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J]. Blood, 2000, 96 (6): 2240-2245.
5. Wellmann S, Guschmann M, Griethe W, Eckert C, von Stackelberg A, Lottaz C, et al. Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF [J]. Leukemia, 2004, 18(5):926-933.
6. Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. Effect of p53 status on tumor response to antiangiogenic therapy [J]. Science, 2002, 295(5559):1526-1528.
7. Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J]. Blood, 1999, 94(16): 3717.
8. Yu JL, May L, Klement P, Weitz JI, Rak J. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy [J]. Semin Thromb Hemost, 2004, 30 (1): 21-30.
9. Nakasaki T, Wads H, Watanabe R, Mori Y, Gabazza EC, Kageyama S, et al. Elevated tissue factor levels in leukemic cell homogenate[J]. Clin Appl Thromb Hemost, 2000, 6 (1): 14-17.